Search Results

There are 4150 results for: content related to: Efficacy and tolerability of mesalazine foam enema (Salofalk foam) for distal ulcerative colitis: a double-blind, randomized, placebo-controlled study

  1. You have free access to this content
    Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis – a pooled analysis

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 9, November 2011, Pages: 1115–1122, L. Leifeld, R. Pfützer, J. Morgenstern, P. R. Gibson, Y. Marakhouski, R. Greinwald, R. Mueller and W. Kruis

    Article first published online : 19 SEP 2011, DOI: 10.1111/j.1365-2036.2011.04840.x

  2. Is Once-Daily Mesalazine Equivalent to the Currently Used Twice-Daily Regimen? A Study Performed in 30 Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 47, Issue 3, March 2007, Pages: 334–342, Dr Peggy Gandia, Dr Isabelle Idier and Dr Georges Houin

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270006296522

  3. You have free access to this content
    The cost-utility of high dose oral mesalazine for moderately active ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 28, Issue 11-12, December 2008, Pages: 1287–1296, A. BUCKLAND and K. BODGER

    Article first published online : 19 SEP 2008, DOI: 10.1111/j.1365-2036.2008.03856.x

  4. You have free access to this content
    Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn’s disease

    Alimentary Pharmacology & Therapeutics

    Volume 25, Issue 12, June 2007, Pages: 1389–1399, A. H. STEINHART, A. FORBES, E. C. MILLS, B. S. RODGERS-GRAY and S. P. L. TRAVIS

    Article first published online : 30 MAR 2007, DOI: 10.1111/j.1365-2036.2007.03324.x

  5. You have free access to this content
    Systematic review: the use of mesalazine in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 23, Issue 7, April 2006, Pages: 841–855, R. BERGMAN and M. PARKES

    Article first published online : 17 MAR 2006, DOI: 10.1111/j.1365-2036.2006.02846.x

  6. Pharmacokinetics of mesalazine pellets in children with inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 10, Issue 5, September 2004, Pages: 626–631, Heleen Wiersma, Johanna C. Escher, Karin Dilger, Dietmar Trenk, Marc A. Benninga, Chris J. van Boxtel and Jan Taminiau

    Article first published online : 14 DEC 2006, DOI: 10.1097/00054725-200409000-00019

  7. You have free access to this content
    A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue 3, March 1999, Pages: 381–388, GIONCHETTI, ARDIZZONE, BENVENUTI, BIANCHI PORRO, BIASCO, CESARI, D'ALBASIO, DE FRANCHIS, MONTELEONE, PALLONE, RANZI, TRALLORI, VALPIANI, VECCHI and CAMPIERI

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00482.x

  8. You have free access to this content
    Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation – a placebo-controlled study

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 3, August 2013, Pages: 264–273, M. Watanabe, H. Nishino, Y. Sameshima, A. Ota, S. Nakamura and T. Hibi

    Article first published online : 5 JUN 2013, DOI: 10.1111/apt.12362

  9. Development and validation of an LC-MS/MS method for the determination of mesalazine in beagle dog plasma and its application to a pharmacokinetic study

    Biomedical Chromatography

    Volume 29, Issue 2, February 2015, Pages: 261–267, Juan Qin, Xin Di, Xin Wang and Youping Liu

    Article first published online : 13 JUN 2014, DOI: 10.1002/bmc.3270

  10. You have free access to this content
    Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue 11, November 1999, Pages: 1413–1417, Frieri, Pimpo, Palumbo, Onori, Viscido, Latella, Galletti, Pantaleoni and Caprilli

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00642.x

  11. You have free access to this content
    Short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 19, Issue 2, January 2004, Pages: 179–189, E. V. Loftus JR, S. V. Kane and D. Bjorkman

    Article first published online : 14 JAN 2004, DOI: 10.1111/j.0269-2813.2004.01827.x

  12. You have free access to this content
    MMX Multi Matrix System® mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 2, July 2007, Pages: 205–215, W. J. SANDBORN, M. A. KAMM, G. R. LICHTENSTEIN, A. LYNE, T. BUTLER and R. E. JOSEPH

    Article first published online : 4 MAY 2007, DOI: 10.1111/j.1365-2036.2007.03361.x

  13. You have free access to this content
    Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months

    Alimentary Pharmacology & Therapeutics

    Volume 12, Issue 12, December 1998, Pages: 1207–1216, Green, Gibson, Kerr, Swarbrick, Lobo, Holdsworth, Crowe, Schofield, Taylor and THE ABACUS INVESTIGATOR GROUP

    Article first published online : 4 JAN 2002, DOI: 10.1046/j.1365-2036.1998.00427.x

  14. You have free access to this content
    Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 8, April 2013, Pages: 767–775, B. Flourié, H. Hagège, G. Tucat, D. Maetz, X. Hébuterne, J. P. Kuyvenhoven, T. G. Tan, M. J. Pierik, A. A. M. Masclee, O. Dewit, C. S. Probert, D. Aoucheta and the MOTUS study investigators

    Article first published online : 4 MAR 2013, DOI: 10.1111/apt.12266

  15. You have free access to this content
    Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon – a placebo-controlled study

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 7, April 2013, Pages: 680–690, W. Kruis, E. Meier, M. Schumacher, O. Mickisch, R. Greinwald, R. Mueller and the German SAG-20 Study Group

    Article first published online : 17 FEB 2013, DOI: 10.1111/apt.12248

  16. You have free access to this content
    Mesalazine downregulates c-Myc in human colon cancer cells. A key to its chemopreventive action?

    Alimentary Pharmacology & Therapeutics

    Volume 25, Issue 12, June 2007, Pages: 1443–1449, E. C. CHU, J. CHAI, A. AHLUWALIA and A. S. TARNAWSKI

    Article first published online : 9 APR 2007, DOI: 10.1111/j.1365-2036.2007.03336.x

  17. You have free access to this content
    Review article: oral, modified-release mesalazine formulations — proprietary versus generic

    Alimentary Pharmacology & Therapeutics

    Volume 17, Issue 10, 15th May 2003, Pages: 1207–1214, A. Forbes, A. Cartwright, S. Marchant, P. Mcintyre and M. Newton

    Article first published online : 16 MAY 2003, DOI: 10.1046/j.1365-2036.2003.01578.x

  18. You have free access to this content
    MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 11, June 2008, Pages: 1094–1102, G. R. LICHTENSTEIN, M. A. KAMM, W. J. SANDBORN, A. LYNE and R. E. JOSEPH

    Article first published online : 22 MAR 2008, DOI: 10.1111/j.1365-2036.2008.03688.x

  19. Probiotics for maintenance of remission in ulcerative colitis

    Intervention Review

    The Cochrane Library

    Khimara Naidoo, Morris Gordon, Andrew O Fagbemi, Adrian G Thomas and Anthony K Akobeng

    Published Online : 7 DEC 2011, DOI: 10.1002/14651858.CD007443.pub2

  20. You have free access to this content
    Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 3, August 2010, Pages: 368–376, F. Hartmann, J. Stein and the BudMesa-Study Group

    Article first published online : 11 MAY 2010, DOI: 10.1111/j.1365-2036.2010.04354.x